SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...

Anti-aging concern Unity Biotechnology, Inc. (UBX) saw its share price collapse after its lead candidate (UBX0101) flunked a Phase 2 study in August 2020. The setback forced a restructuring with a ...

Unity beat sales and earnings expectations for the second quarter, and its stock initially rose following its Q2 report. The company's forward guidance raised concerns about the timeline for the ...

Nasdaq provides an interactive stock information chart to view history. Downloadable stock history data table is also accessible by clicking on Data Table on the navigation tool bar. If you have ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

Unity stock has posted double-digit gains on the heels of its third-quarter earnings release. Sales and profits topped Wall Street's expectations in Q3. Unity's new AI-powered advertising platform is ...